Ontario Institute for Cancer Research and Centre for Drug Research and Development announces call for pre-proposals for early-stage research

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

THE CENTRE FOR DRUG RESEARCH AND DEVELOPMENT and the Ontario Institute for Cancer Research announced a call for pre-proposals from Canadian academic investigators focused on early-stage technologies.

The two organizations are looking to collaborate on projects that will advance the preclinical development of targeted therapeutics or approaches including small molecules, biologics and cell-based therapies.

Unlike traditional grants, CDRD and OICR will work in partnership with academic investigators to develop collaborative project plans addressing the steps required to advance cancer therapies from the lab to the clinic. Projects will be milestone-driven with clear go/no-go decision points with budgets depending on the scope of the project.

More information on the program can be found on the CDRD website.

YOU MAY BE INTERESTED IN

I write a weekly blog for Georgetown University’s Lombardi Comprehensive Cancer Center community. Here I share an updated version of a blog post I wrote in September 2024, now supplemented by some poems I have written over the years that inspired paintings by my wife Harriet Weiner, who is a much better artist than I am a poet or writer. 

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login